EcoDrugPlus

Histone Deacetylase 1

Ensembl ID : ENSUPAG00010005322
Gene Symbol: HDAC1
1 Cross references
278 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSUPAG00010009388
Gene Symbol: HDAC11
3 Cross references
197 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSUPAG00010023155
Gene Symbol: HDAC2
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSUPAG00010012085
Gene Symbol: HDAC3
3 Cross references
156 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSUPAG00010005212
Gene Symbol: HDAC4
1 Cross references
263 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSUPAG00010002429
Gene Symbol: HDAC5
1 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSUPAG00010002848
Gene Symbol: HDAC6
3 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSUPAG00010002786
Gene Symbol: HDAC7
3 Cross references
260 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSUPAG00010016655
Gene Symbol: HDAC8
1 Cross references
201 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSUPAG00010012420
Gene Symbol: HDAC9
1 Cross references
234 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 2

Ensembl ID : ENSUPAG00010017937
Gene Symbol: LOC113192786
2 Cross references
165 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSUPAG00010016557
Gene Symbol: HSD11B1
1 Cross references
248 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).